ResMed | RMD - 销售收入

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 33.2B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	销售	更改		日
Ansell	USD 1.03B		192.2M	2025-12
Artivion	USD 115.99M		2.6M	2025-12
AtriCure	USD 153.6M		12.4M	2026-06
Baxter International	USD 2.96B		260M	2026-06
Cochlear	AUD 1.18B		590.35M	2025-12
Cooper Companies	USD 1.08B		57.4M	2026-03
CSL	USD 8.33B		4.79B	2025-12
Dexcom	USD 1.31B		120M	2026-06
Edwards Lifesciences	USD 1.74B		90M	2026-06
Fisher Paykel Healthcare	NZD 1.24B		137.8M	2026-06
Globus Medical	USD 789.61M		29.76M	2026-06
Haemonetics	USD 339M		7M	2026-06
Idexx Laboratories	USD 1.22B		80M	2026-06
Inogen	USD 74.93M		504K	2024-09
Insulet	USD 801.7M		40M	2026-06
Integra LifeSciences	USD 418.8M		26.9M	2026-06
Intuitive Surgical	USD 2.89B		120M	2026-06
Medtronic	USD 9.8B		800M	2026-03
Philips	EUR 4.36B		450M	2026-06
Ramsay Health Care	AUD 9.34B		82.2M	2025-12
ResMed	USD 1.46B		60M	2026-06
Sigma Healthcare	AUD 1.68B		188.65M	2024-12
Sonic Healthcare	AUD 5.45B		470M	2025-12
Steris	USD 1.5B		90M	2026-06
Teleflex	USD 570.3M		22M	2026-06
Thermo Fisher Scientific	USD 11.99B		980M	2026-06